祥生医疗: 祥生医疗2024年年度股东大会决议公告

Meeting Overview - The shareholder meeting of Wuxi Xiangsheng Medical Technology Co., Ltd. was held on May 16, 2025, at the company's conference room [1] - A total of 40 ordinary shareholders attended the meeting, representing 82,221,541 voting rights, which accounts for 73.3305% of the total voting rights of the company [1] Voting Results - All non-cumulative voting proposals were approved with a significant majority, including: - 99.9857% of ordinary shareholders voted in favor of the proposals, with only 0.0143% against [2] - The voting results for the financial budget report for 2025 also showed a similar trend, with 99.9857% approval [2] - The meeting's voting procedures complied with the Company Law and the company's articles of association, confirming the legality and validity of the meeting [3] Legal Compliance - The lawyers present at the meeting confirmed that the convening and voting procedures adhered to relevant laws and regulations, ensuring the legitimacy of the meeting and its outcomes [3]